oRNA, Delivery
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
150
NCT05828459
First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 10, 2023
Completion: Jul 31, 2027
Loading map...